Item 7.01 Regulation FD Disclosure.





Acquisition of preCARDIA


On June 1, 2021, ABIOMED, Inc. (the "Company," "we" or "us") issued a press release reporting that it entered into a share purchase agreement with preCARDIA providing for the acquisition of all of the issued shares of preCARDIA, developer of a proprietary catheter and controller that will complement the Company's product portfolio to expand options for patients with acute decompensated heart failure. The preCARDIA system is available for investigational use only and is not approved for use outside of clinical studies. Terms of the acquisition are not being disclosed at this time. A copy of the press release is set forth as Exhibit 99.1 and is incorporated herein by reference.

Caution Concerning Forward-Looking Statements

This Form 8-K contains information that includes or is based on forward-looking statements within the meaning of the federal securities laws that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such statements include, but are not limited to, those regarding our financial performance and the impact of the COVID-19 pandemic on our operations and financial results and are subject to, among other risks, the COVID-19 pandemic and any related policies and actions by governments or other third parties. Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q that we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that affect the likelihood that actual results will differ from those contained in the forward-looking statements.

The information contained in Item 7.01 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit   Description
99.1        Press release dated June 1, 2021

--------------------------------------------------------------------------------




                                 Exhibit Index



Exhibit   Description
 99.1       Press release dated June 1, 2021

  104     Cover Page Interactive Data File (embedded with the Inline XBRL document)




--------------------------------------------------------------------------------

© Edgar Online, source Glimpses